Ribozyme targeting of HER-2 inhibits pancreatic cancer cell growth in vivo

Author： Thybusch-Bernhardt A.   Aigner A.   Beckmann S.   Czubayko F.   Juhl H.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.37, Iss.13, 2001-09, pp. : 1688-1694

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the βcatenin/Ecadherin pathway

By            

Experimental and Therapeutic Medicine, Vol. 10, Iss. 4, 2015-01 ,pp. : 1311-1316

Spandidos Publications

Access to resources Recommend Favorite

CLC604 preferentially inhibits the growth of HER2-overexpressing cancer cells and sensitizes these cells to the inhibitory effect of Taxol in vitro and in vivo

By                    

Oncology Reports, Vol. 30, Iss. 4, 2013-01 ,pp. : 1762-1772

Spandidos Publications

Access to resources Recommend Favorite

Lentivirus-mediated RNA interference targeting WWTR1 in human colorectal cancer cells inhibits cell proliferation in vitro and tumor growth in vivo

By            

Oncology Reports, Vol. 28, Iss. 1, 2012-01 ,pp. : 179-185

Spandidos Publications

Access to resources Recommend Favorite

Combined treatment of XIAP-targeting shRNA and celecoxib synergistically inhibits the tumor growth of nonsmall cell lung cancer cells in vitro and in vivo

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1079-1088

Spandidos Publications

Access to resources Recommend Favorite

α-eleostearic acid inhibits growth and induces apoptosis in breast cancer cells via HER2/HER3 signaling

By              

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 993-998

Spandidos Publications

Access to resources Recommend Favorite